Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus Infection Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07177508
What this trial is testing

First Year Impact of Nirsevimab on Paediatric Respiratory Syncytial Virus Infection and Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Viral (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Prevention
Nicola Irwin 2,355
Testing effectiveness (Phase 2)Study completedNCT02878330
What this trial is testing

Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 1,453
Early research (Phase 1)Active Not RecruitingNCT06556147
What this trial is testing

RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults

Who this might be right for
Healthy Volunteers
Sanofi 144
Large-scale testing (Phase 3)Study completedNCT00121108
What this trial is testing

MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States

Who this might be right for
Healthy
MedImmune LLC 2,127
Large-scale testing (Phase 3)Ended earlyNCT04605159
What this trial is testing

A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 11,194
Large-scale testing (Phase 3)Ended earlyNCT05242432
What this trial is testing

Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants

Who this might be right for
Respiratory Syncytial Virus Prevention
Janssen Pharmaceutical K.K. 2,192
Testing effectiveness (Phase 2)Looking for participantsNCT06597916
What this trial is testing

RSV Vaccination in Immunocompromised Patients.

Who this might be right for
RSV Infection
Medical University of Vienna 200
Testing effectiveness (Phase 2)Looking for participantsNCT07762014
What this trial is testing

RBCG-N-RSV Vaccine in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infection PreventionTuberculosis Prevention
Biothervax SpA 200
Early research (Phase 1)Study completedNCT06237296
What this trial is testing

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionHealthy VolunteersMetapneumovirus Infection
Sanofi Pasteur, a Sanofi Company 558
Large-scale testing (Phase 3)Study completedNCT06083623
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants

Who this might be right for
Respiratory Syncytial Virus Infections
Zhuhai Trinomab Pharmaceutical Co., Ltd. 2,282
Early research (Phase 1)Study completedNCT05970744
What this trial is testing

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Who this might be right for
Respiratory Syncytial Virus Infections
Tatyana Zubkova 60
Testing effectiveness (Phase 2)Ended earlyNCT05327816
What this trial is testing

Various Respiratory Syncytial Virus (RSV) Pre-Fusion (preF)-Based Vaccine Formulations in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus-associated Lower Respiratory Tract Disease Prevention
Janssen Vaccines & Prevention B.V. 132
Large-scale testing (Phase 3)Study completedNCT04908683
What this trial is testing

An Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial VirusesLower Respiratory Tract Disease
Janssen Vaccines & Prevention B.V. 25,236
Testing effectiveness (Phase 2)Ended earlyNCT02508194
What this trial is testing

Evaluate the Efficacy of MEDI7510 in Older Adults

Who this might be right for
Respiratory Syncytial Virus
MedImmune LLC 1,900
Not applicableStudy completedNCT01545245
What this trial is testing

Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm Infants

Who this might be right for
Atopic AsthmaRecurrent Wheezing
Tokai University 343
Early research (Phase 1)Study completedNCT01909843
What this trial is testing

ALX-0171 Safety Study in Adults With Hyperresponsive Airways

Who this might be right for
Respiratory Syncytial Virus Infection
Ablynx, a Sanofi company 24
Large-scale testing (Phase 3)Not Yet RecruitingNCT07041190
What this trial is testing

Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination.

Who this might be right for
RSV Immunization
PENTA Foundation 1,500
Early research (Phase 1)Study completedNCT06583031
What this trial is testing

Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years

Who this might be right for
RSV InfectionhMPV
Sanofi Pasteur, a Sanofi Company 385
Post-approval studies (Phase 4)Study completedNCT00001903
What this trial is testing

Prevention of RSV Infections in Bone Marrow Transplant Recipients

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 120
Early research (Phase 1)UnknownNCT02958540
What this trial is testing

Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine

Who this might be right for
Respiratory Syncytial Viral Infections
Mucosis BV 48
Next Page